Distribución real y potencial del género hiperparasitoide Mesochorus Gravenhorst (Ichneumonidae: Mesochorinae) en Brasil

Mesochorus species are hyperparasitoids capable of nullifying biological control agents. This study is the first to map and predict the distribution of this genus in Brazil. Species distribution modeling was used to estimate the potential distribution of Mesochorus. We obtained 72 occurrence records of 49 Mesochorus species, being 30 endemics. According to our prediction model, this genus can be distributed in all Brazilian biomes, with higher suitability of occurrence in the Atlantic Forest and lower in the Caatinga and Pampa.Las especies de Mesochorus son hiperparasitoides capaces de anular los agentes de control biológico. Este estudio es el primero en mapear y predecir la distribución de este género en Brasil. Se utilizó un modelo de distribución de especies para estimar la distribución potencial de Mesochorus. Obtuvimos 72 registros de ocurrencia de 49 especies de Mesochorus, siendo 30 endémicas. De acuerdo con nuestro modelo de predicción, este género se puede distribuir en todos los biomas brasileños, con una mayor idoneidad de ocurrencia en el Bosque Atlántico y menor en la Caatinga y Pampa

Fauna de abelhas nativa em plantações de tomate : uma comparação de métodos de amostragem ativa e de armadilha

O tomate é amplamente cultivado em todo o mundo e requer polinização por abelhas nativas ou manejadas para realizar o pleno potencial de produção dos frutos. Para investigar a riqueza e abundância de espécies de abelhas nativas em plantações de tomate do Centro-Oeste do Brasil, dois métodos de amostragem (armadilhas pan-trap e amostragem ativa) foram utilizados em nove propriedades de junho a setembro de 2011. Um total de 465 indivíduos de 44 espécies foi coletado. A composição das espécies de abelhas amostradas diferiu dependendo do método utilizado. Vinte e duas espécies foram capturadas exclusivamente em armadilhas, 13 outras por meio de amostragem ativa e nove por ambos os métodos. A maioria das espécies de abelhas capturadas neste estudo pode ser considerada polinizadores eficazes do tomate, porque elas podem executar a polinização por vibração. Vibrando seus músculos torácicos, essas abelhas podem liberar o pólen das anteras para seus próprios corpos e para os estigmas da mesma flor, uma vez que eles estão dentro do cone de anteras da variedade do tomate estudado. Ambos os métodos amostraram espécies exclusivas de abelhas vibradoras. No entanto, as armadilhas capturaram abelhas vibradoras e não vibradoras indiscriminadamente e o método ativo amostrou principalmente a abelha vibradora. As coletas utilizando armadilhas e amostragens ativas foram complementares. O uso de apenas um método de amostragem não fornece um entendimento completo da riqueza de espécies de polinizadores de tomate no campo.The tomato is widely cultivated throughout the world and requires pollination by wild or managed bees to realize its full-potential fruit production. Two different sampling methods (pan trapping and active sampling) were employed in nine different properties from June to September of 2011 to investigate the richness and abundance of native bee species present in tomato crops of Center-West Brazil. A total of 465 individuals of 44 species were collected, with the composition of sampled bee species differing between the methods used. Twenty-two species were exclusively captured in pan traps, 13 others through active sampling and nine by both methods. Most of the sampled bee species can be considered effective pollinators of the tomato because they can perform buzz-pollination. By vibration, these bees can liberate pollen from anthers into the air or onto their own bodies and the stigmas of the same flower because the stigmas of the studied tomato variety are within the anther cone. Both methods exclusively sampled some species of buzz-pollinating bees, however, pan-trapping captured buzzing and non-buzzing visitors indiscriminately while active sampling captured more buzzing bees. Pan-trapping and active sampling appear to complement each other, and so the use of only one or the other would not provide a full understanding of the species richness of tomato pollinators in the field

ALDH1A2 (RALDH2) genetic variation in human congenital heart disease

Abstract\ud \ud \ud \ud Background\ud \ud Signaling by the vitamin A-derived morphogen retinoic acid (RA) is required at multiple steps of cardiac development. Since conversion of retinaldehyde to RA by retinaldehyde dehydrogenase type II (ALDH1A2, a.k.a RALDH2) is critical for cardiac development, we screened patients with congenital heart disease (CHDs) for genetic variation at the ALDH1A2 locus.\ud \ud \ud \ud Methods\ud \ud One-hundred and thirty-three CHD patients were screened for genetic variation at the ALDH1A2 locus through bi-directional sequencing. In addition, six SNPs (rs2704188, rs1441815, rs3784259, rs1530293, rs1899430) at the same locus were studied using a TDT-based association approach in 101 CHD trios. Observed mutations were modeled through molecular mechanics (MM) simulations using the AMBER 9 package, Sander and Pmemd programs. Sequence conservation of observed mutations was evaluated through phylogenetic tree construction from ungapped alignments containing ALDH8 s, ALDH1Ls, ALDH1 s and ALDH2 s. Trees were generated by the Neighbor Joining method. Variations potentially affecting splicing mechanisms were cloned and functional assays were designed to test splicing alterations using the pSPL3 splicing assay.\ud \ud \ud \ud Results\ud \ud We describe in Tetralogy of Fallot (TOF) the mutations Ala151Ser and Ile157Thr that change non-polar to polar residues at exon 4. Exon 4 encodes part of the highly-conserved tetramerization domain, a structural motif required for ALDH oligomerization. Molecular mechanics simulation studies of the two mutations indicate that they hinder tetramerization. We determined that the SNP rs16939660, previously associated with spina bifida and observed in patients with TOF, does not affect splicing. Moreover, association studies performed with classical models and with the transmission disequilibrium test (TDT) design using single marker genotype, or haplotype information do not show differences between cases and controls.\ud \ud \ud \ud Conclusion\ud \ud In summary, our screen indicates that ALDH1A2 genetic variation is present in TOF patients, suggesting a possible causal role for this gene in rare cases of human CHD, but does not support the hypothesis that variation at the ALDH1A2 locus is a significant modifier of the risk for CHD in humans.Work supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 01/000090; 00/030722; 01/142381; 02/113402; 03/099982; 04/116068; 04/157044 and Conselho Nacional de Desenvolvimento Científico e Tecnológico 481872/20078. We would like to thank the careful work and thoughtful suggestions of the two reviewers responsible for the reviewing editorial process.Work supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 01/00009-0; 00/03072-2; 01/14238-1; 02/11340-2; 03/09998-2; 04/11606-8; 04/15704-4 and Conselho Nacional de Desenvolvimento Científico e Tecnológico 481872/2007-8. We would like to thank the careful work and thoughtful suggestions of the two reviewers responsible for the reviewing editorial process

Diretriz da Sociedade Brasileira de Cardiologia sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas

This guideline aimed to update the concepts and formulate the standards of conduct and scientific evidence that support them, regarding the diagnosis and treatment of the Cardiomyopathy of Chagas disease, with special emphasis on the rationality base that supported it.  Chagas disease in the 21st century maintains an epidemiological pattern of endemicity in 21 Latin American countries. Researchers and managers from endemic and non-endemic countries point to the need to adopt comprehensive public health policies to effectively control the interhuman transmission of T. cruzi infection, and to obtain an optimized level of care for already infected individuals, focusing on diagnostic and therapeutic opportunistic opportunities.   Pathogenic and pathophysiological mechanisms of the Cardiomyopathy of Chagas disease were revisited after in-depth updating and the notion that necrosis and fibrosis are stimulated by tissue parasitic persistence and adverse immune reaction, as fundamental mechanisms, assisted by autonomic and microvascular disorders, was well established. Some of them have recently formed potential targets of therapies.  The natural history of the acute and chronic phases was reviewed, with enhancement for oral transmission, indeterminate form and chronic syndromes. Recent meta-analyses of observational studies have estimated the risk of evolution from acute and indeterminate forms and mortality after chronic cardiomyopathy. Therapeutic approaches applicable to individuals with Indeterminate form of Chagas disease were specifically addressed. All methods to detect structural and/or functional alterations with various cardiac imaging techniques were also reviewed, with recommendations for use in various clinical scenarios. Mortality risk stratification based on the Rassi score, with recent studies of its application, was complemented by methods that detect myocardial fibrosis.  The current methodology for etiological diagnosis and the consequent implications of trypanonomic treatment deserved a comprehensive and in-depth approach. Also the treatment of patients at risk or with heart failure, arrhythmias and thromboembolic events, based on pharmacological and complementary resources, received special attention. Additional chapters supported the conducts applicable to several special contexts, including t. cruzi/HIV co-infection, risk during surgeries, in pregnant women, in the reactivation of infection after heart transplantation, and others.     Finally, two chapters of great social significance, addressing the structuring of specialized services to care for individuals with the Cardiomyopathy of Chagas disease, and reviewing the concepts of severe heart disease and its medical-labor implications completed this guideline.Esta diretriz teve como objetivo principal atualizar os conceitos e formular as normas de conduta e evidências científicas que as suportam, quanto ao diagnóstico e tratamento da CDC, com especial ênfase na base de racionalidade que a embasou. A DC no século XXI mantém padrão epidemiológico de endemicidade em 21 países da América Latina. Investigadores e gestores de países endêmicos e não endêmicos indigitam a necessidade de se adotarem políticas abrangentes, de saúde pública, para controle eficaz da transmissão inter-humanos da infecção pelo T. cruzi, e obter-se nível otimizado de atendimento aos indivíduos já infectados, com foco em oportunização diagnóstica e terapêutica. Mecanismos patogênicos e fisiopatológicos da CDC foram revisitados após atualização aprofundada e ficou bem consolidada a noção de que necrose e fibrose sejam estimuladas pela persistência parasitária tissular e reação imune adversa, como mecanismos fundamentais, coadjuvados por distúrbios autonômicos e microvasculares. Alguns deles recentemente constituíram alvos potenciais de terapêuticas. A história natural das fases aguda e crônica foi revista, com realce para a transmissão oral, a forma indeterminada e as síndromes crônicas. Metanálises recentes de estudos observacionais estimaram o risco de evolução a partir das formas aguda e indeterminada e de mortalidade após instalação da cardiomiopatia crônica. Condutas terapêuticas aplicáveis aos indivíduos com a FIDC foram abordadas especificamente. Todos os métodos para detectar alterações estruturais e/ou funcionais com variadas técnicas de imageamento cardíaco também foram revisados, com recomendações de uso nos vários cenários clínicos. Estratificação de risco de mortalidade fundamentada no escore de Rassi, com estudos recentes de sua aplicação, foi complementada por métodos que detectam fibrose miocárdica. A metodologia atual para diagnóstico etiológico e as consequentes implicações do tratamento tripanossomicida mereceram enfoque abrangente e aprofundado. Também o tratamento de pacientes em risco ou com insuficiência cardíaca, arritmias e eventos tromboembólicos, baseado em recursos farmacológicos e complementares, recebeu especial atenção. Capítulos suplementares subsidiaram as condutas aplicáveis a diversos contextos especiais, entre eles o da co-infecção por T. cruzi/HIV, risco durante cirurgias, em grávidas, na reativação da infecção após transplante cardíacos, e outros.    Por fim, dois capítulos de grande significado social, abordando a estruturação de serviços especializados para atendimento aos indivíduos com a CDC, e revisando os conceitos de cardiopatia grave e suas implicações médico-trabalhistas completaram esta diretriz.&nbsp